During the past decade, Gabinety Lekarskie Rivermed conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gabinety Lekarskie Rivermed" are "Active Systemic Lupus Erythematosus" (1 trials), "Atopic Dermatitis" (1 trials), "Crohn's Disease" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Gabinety Lekarskie Rivermed" in a lesser frequency.

Most popular intervention types in "Gabinety Lekarskie Rivermed" are "Drug" (4 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abrocitinib 200 mg" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Dupilumab 300 mg" (1 trials) and "Efavaleukin Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gabinety Lekarskie Rivermed" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Gabinety Lekarskie Rivermed". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gabinety Lekarskie Rivermed, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gabinety Lekarskie Rivermed, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".